We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+11.59%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.06B
AUM Growth
+$153M
Cap. Flow
+$77M
Cap. Flow %
7.28%
Top 10 Hldgs %
8.36%
Holding
708
New
178
Increased
217
Reduced
190
Closed
93

Top Buys

Rank Stock Value
1
VLTO icon
Veralto
VLTO
+$4.25M
2
MTB icon
M&T Bank
MTB
+$4.04M
3
BJ icon
BJs Wholesale Club
BJ
+$3.86M
4
RCI icon
Rogers Communications
RCI
+$3.84M
5
INTC icon
Intel
INTC
+$3.84M

Top Sells

Rank Stock Value
1
RACE icon
Ferrari
RACE
+$53.1M
2
STLA icon
Stellantis
STLA
+$8.81M
3
HUBB icon
Hubbell
HUBB
+$4.16M
4
AMAT icon
Applied Materials
AMAT
+$3.47M
5
DOCN icon
DigitalOcean
DOCN
+$3.46M

Sector Composition

Rank Sector Weight
1 Technology 22.82%
2 Healthcare 18.21%
3 Industrials 14.27%
4 Consumer Discretionary 12.02%
5 Financials 9.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNEX icon
251
StoneX
SNEX
$8.72B
$1.49M 0.14%
71,550
+23,905
+50% +$478K
ROKU icon
252
Roku
ROKU
$21.6B
$1.49M 0.14%
+22,836
New +$1.78M
LPX icon
253
Louisiana-Pacific
LPX
$5.14B
$1.49M 0.14%
17,700
+13,200
+293% +$949K
UNFI icon
254
United Natural Foods
UNFI
$3.04B
$1.48M 0.14%
128,631
+104,084
+424% +$1.51M
ZM icon
255
Zoom
ZM
$27.1B
$1.45M 0.14%
+22,246
New +$1.48M
KW
256
DELISTED
Kennedy-Wilson Holdings
KW
$1.45M 0.14%
+169,059
New +$1.66M
BPMC
257
DELISTED
Blueprint Medicines
BPMC
$1.44M 0.14%
15,129
-4,398
-23% -$377K
GH icon
258
Guardant Health
GH
$19.1B
$1.42M 0.13%
68,666
-21,417
-24% -$459K
BRKR icon
259
Bruker
BRKR
$9.4B
$1.42M 0.13%
15,073
+1,485
+11% +$119K
AES icon
260
AES
AES
$10.6B
$1.41M 0.13%
+78,600
New +$1.31M
HAPN
261
Happen Inc
HAPN
$2.14B
$1.41M 0.13%
160,311
-10,156
-6% -$85.1K
KAI icon
262
Kadant
KAI
$3.58B
$1.41M 0.13%
+4,284
New +$1.29M
RES icon
263
RPC Inc
RES
$1.13B
$1.41M 0.13%
181,598
+21,091
+13% +$152K
SNCY
264
DELISTED
Sun Country Airlines
SNCY
$1.38M 0.13%
91,739
+62,964
+219% +$907K
CWAN
265
DELISTED
Clearwater Analytics
CWAN
$1.38M 0.13%
78,227
+36,720
+88% +$682K
CIVI
266
DELISTED
Civitas Resources
CIVI
$1.37M 0.13%
+18,063
New +$1.21M
CLS icon
267
Celestica
CLS
$37.8B
$1.37M 0.13%
+30,400
New +$1.15M
VSTS icon
268
Vestis
VSTS
$1.97B
$1.36M 0.13%
+70,571
New +$1.4M
CBRL icon
269
Cracker Barrel
CBRL
$1.26B
$1.36M 0.13%
+18,670
New +$1.35M
UTHR icon
270
United Therapeutics
UTHR
$26.1B
$1.34M 0.13%
5,840
-3,607
-38% -$814K
EFX icon
271
Equifax
EFX
$22B
$1.34M 0.13%
5,005
+5
+0.1% +$1.27K
FTDR icon
272
Frontdoor
FTDR
$5.27B
$1.34M 0.13%
+41,031
New +$1.33M
BTU icon
273
Peabody Energy
BTU
$2.54B
$1.33M 0.13%
55,028
-4,952
-8% -$125K
PRM icon
274
Perimeter Solutions
PRM
$5.66B
$1.33M 0.13%
178,955
+688
+0.4% +$3.7K
GFL icon
275
GFL Environmental
GFL
$14.5B
$1.31M 0.12%
+38,052
New +$1.31M

Similar funds

PDT Partners's Q1 2024 Portfolio in Review

As of Q1 2024, PDT Partners held 708 positions worth $1.06B, up 17% from $905M the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.

PDT Partners deployed $77M of net new capital in Q1 2024, opening 178 new positions and adding to 217 existing holdings. Its largest new stake was Veralto: 51,311 shares worth $4.55M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Ferrari, an estimated $53.1M trimmed.

  • PDT Partners's largest Q1 2024 buy was Veralto: 51,311 shares worth $4.55M.
  • PDT Partners added most to BJs Wholesale Club in Q1 2024, an estimated $3.86M increase.
  • PDT Partners's biggest Q1 2024 reduction was Ferrari, cutting an estimated $53.1M.
  • PDT Partners fully exited Royalty Pharma in Q1 2024, selling an estimated $3.4M.
  • PDT Partners's ten largest holdings make up 8.4% of its $1.06B portfolio in Q1 2024.
  • PDT Partners opened 178 new positions and closed 93 in Q1 2024.
  • PDT Partners's portfolio value rose 17% quarter-over-quarter to $1.06B.

Based on PDT Partners's 13F filing for Q1 2024, filed 15 May 2024.